![Neil Cashman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Neil Cashman
Gründer bei
PROMIS NEUROSCIENCES, INC.
Vermögen: 122 625 $ am 30.06.2026
Profil
Neil R.
Cashman is the founder of Caprion Proteomics, Inc., founded in 2000, and ProMIS Neurosciences, Inc., founded in 2004, where Dr. Cashman holds the title of Director & Chief Scientific Officer.
Dr. Cashman currently serves as Director-ALS Clinic at Vancouver General Hospital since 2005, Director at ALS Society of British Columbia, and Director at Alberta Innovates BioSolutions.
Former positions include Director-Neuromuscular Clinic at Sunnybrook & Womens Foundation, Director-UBC ALS Centre & Professor at the University of British Columbia from 2005 to 2022, and Professor at the University of Toronto from 1998 to 2005.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.05.2026 | 9 318 ( 0,1 % ) | 122 625 $ | 30.06.2026 |
Aktive Positionen von Neil Cashman
| Unternehmen | Position | Beginn |
|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Gründer | 23.01.2004 |
Vancouver General Hospital | Corporate Officer/Principal | 01.07.2005 |
Alberta Innovates BioSolutions
 Alberta Innovates BioSolutions BiotechnologyHealth Technology Develops bioindustrial technologies and natural products | Direktor/Vorstandsmitglied | - |
ALS Society of British Columbia
 ALS Society of British Columbia Miscellaneous Commercial ServicesCommercial Services Operates as an association which provides support to ALS patients | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Neil Cashman
| Unternehmen | Position | Ende |
|---|---|---|
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 02.01.2022 |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2005 |
Caprion Proteomics, Inc.
 Caprion Proteomics, Inc. Medical SpecialtiesHealth Technology Provides proteomics and immune monitoring services to the pharmaceutical and biotechnology industry | Gründer | - |
Sunnybrook & Womens Foundation | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
80
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
ProMIS Neurosciences, Inc.
 ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sunnybrook & Womens Foundation | |
Vancouver General Hospital | |
ALS Society of British Columbia
ALS Society of British Columbia Miscellaneous Commercial ServicesCommercial Services Operates as an association which provides support to ALS patients | Commercial Services |
Alberta Innovates BioSolutions
Alberta Innovates BioSolutions BiotechnologyHealth Technology Develops bioindustrial technologies and natural products | Health Technology |
Caprion Proteomics, Inc.
Caprion Proteomics, Inc. Medical SpecialtiesHealth Technology Provides proteomics and immune monitoring services to the pharmaceutical and biotechnology industry | Health Technology |
